Skip to content

Member

Aurelijus VERYGA

ECR · Lithuania

Group
ECR
Country
Lithuania
Roll-call participation
90.8 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
90.2 %ⓘ of 559 votes where the group had a line · ECR median 87.7 %
More facts (5)
National party
LVZS Lietuvos valstiečių ir žaliųjų sąjunga
In office
Since 16 Jul 2024
Against clear line
22 of 462 votesⓘ
Committees
ENVI, SANT (substitute)
Member id
256811
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

90.8 %

563 of 620 final votes while in office

ECR median: 91.9 % (−1.1 pts)

Chamber median: 90.6 %

With majority line ⓘ

90.2 %

504 of 559 votes where their group had a line

ECR median: 87.7 % (+2.5 pts)

Against clear line ⓘ

4.8 %

22 of 462 votes where their group had a clear line

6 opposite (for ↔ against), 7 abstained against the line, 9 voted for or against when the line was to abstain

Abstention ⓘ

10.5 %

59 of 563 votes cast

Participation 90.8 % — ECR median 91.9 %, 79 members.ⓘ
Data as a table
Participation among the 79 members of the ECR with enough votes.
FigureParticipation
Aurelijus VERYGA90.8 %
ECR median91.9 %
Lowest in the group51.0 %
Highest in the group99.8 %
Members79
With majority line 90.2 % — ECR median 87.7 %, 79 members.ⓘ
Data as a table
With majority line among the 79 members of the ECR with enough votes.
FigureWith majority line
Aurelijus VERYGA90.2 %
ECR median87.7 %
Lowest in the group46.1 %
Highest in the group94.6 %
Members79
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of ECR; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
29 Apr 2026Discharge 2024: European Public Prosecutor’s Office Discharge decision adopted 454 for, 161 against, 29 abstainedPosition: For ≠ groupMajority line: Against
29 Apr 2026Discharge 2024: Agencies Discharge decision adopted 475 for, 107 against, 71 abstainedPosition: For Majority line: Abstained
29 Apr 2026Discharge 2024: Joint Undertakings Discharge decision adopted 525 for, 104 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/008 BE/Liberty - Belgium Passed 586 for, 48 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Genetically modified soybean MON 94637 Objection passed 412 for, 145 against, 11 abstainedPosition: For Majority line: For
29 Apr 2026Situation of fundamental rights in the European Union in 2024 and 2025 Adopted 328 for, 199 against, 98 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Adopted 387 for, 191 against, 46 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Adopted 416 for, 190 against, 15 abstainedPosition: Against Majority line: Against
28 Apr 2026Generalised scheme of tariff preferences Passed 459 for, 127 against, 70 abstainedPosition: Abstained Majority line: Abstained
28 Apr 2026Welfare of dogs and cats and their traceability Passed 558 for, 35 against, 52 abstainedPosition: For Majority line: For
28 Apr 2026Amendments to Biocidal Products Regulation as regards the extension of certain data protection periods Passed 591 for, 54 against, 8 abstainedPosition: For Majority line: For
28 Apr 2026European Globalisation Adjustment Fund: workers affected by imminent job displacement Passed 566 for, 67 against, 26 abstainedPosition: For Majority line: For
28 Apr 2026Interim report on the proposal for the multiannual financial framework for 2028-2034 Interim report adopted 370 for, 201 against, 84 abstainedPosition: For Majority line: Tie
28 Apr 2026Guidelines for the 2027 budget - Section III Adopted 389 for, 191 against, 75 abstainedPosition: Abstained Majority line: Abstained
28 Apr 2026Amendments to Parliament's Rules of Procedure concerning appointments to Union agencies and bodies (Rule 135) Adopted 657 for, 0 against, 3 abstainedPosition: For Majority line: For
28 Apr 2026Control of the financial activities of the European Investment Bank Group – annual report 2024 Adopted 377 for, 254 against, 31 abstainedPosition: For Majority line: For
28 Apr 2026Importance of consent-based rape legislation in the EU Adopted 447 for, 160 against, 43 abstainedPosition: Against Majority line: Against
28 Apr 2026Protection of the European Union’s financial interests – combating fraud – annual report 2024 Rejected 231 for, 389 against, 33 abstainedPosition: For Majority line: For
28 Apr 2026The role of ocean diplomacy for the competitiveness of EU fisheries and aquaculture Adopted 430 for, 107 against, 115 abstainedPosition: For Majority line: For
28 Apr 2026Control, transparency and traceability of performance-based instruments Adopted 527 for, 85 against, 33 abstainedPosition: For Majority line: For
28 Apr 2026Enhancing connectivity, preserving cultural heritage and driving local excellence in European tourism – destination management and regional tourism growth Adopted 439 for, 42 against, 129 abstainedPosition: Abstained Majority line: Abstained
28 Apr 2026Extension of the term of office of the Special Committee on the European Democracy Shield Adopted 422 for, 202 against, 9 abstainedPosition: Against Majority line: Against
26 Mar 2026Common system for the return of third-country nationals staying illegally in the Union (Return Regulation) Negotiating mandate approved 389 for, 206 against, 32 abstainedPosition: For Majority line: For
26 Mar 2026Combating corruption Passed 581 for, 21 against, 42 abstainedPosition: For Majority line: For
26 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Failed 228 for, 311 against, 92 abstainedPosition: For Majority line: Abstained
26 Mar 2026Adjustment of customs duties and opening of tariff quotas for the import of certain goods originating in the United States of America Passed 417 for, 154 against, 71 abstainedPosition: For Majority line: For
26 Mar 2026Non-application of customs duties on imports of certain goods Passed 437 for, 144 against, 60 abstainedPosition: For Majority line: For
26 Mar 2026Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) Passed 569 for, 45 against, 23 abstainedPosition: For Majority line: For
26 Mar 2026United Nations Convention on the International Effects of Judicial Sales of Ships Consent given 605 for, 3 against, 9 abstainedPosition: For Majority line: For
26 Mar 2026EU-China Agreement: modification of concessions on all the tariff rate quotas included in the EU Schedule CLXXV Consent given 603 for, 3 against, 33 abstainedPosition: For Majority line: For
26 Mar 2026EU-Lebanon Agreement for scientific and technological cooperation setting, participation of Lebanon in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 618 for, 6 against, 5 abstainedPosition: For Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/005 AT/KTM - Austria Passed 584 for, 39 against, 13 abstainedPosition: For Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/007 BE/Casa - Belgium Passed 575 for, 48 against, 10 abstainedPosition: For Majority line: For
26 Mar 2026Union framework for the national calculation of life-cycle global warming potential Objection failed 208 for, 414 against, 10 abstainedPosition: For Majority line: For
26 Mar 2026Global Gateway – past impacts and future orientation Adopted 371 for, 146 against, 80 abstainedPosition: Abstained Majority line: Abstained
12 Mar 2026Calculation of emission credits for heavy-duty vehicles for the reporting periods of the years 2025 to 2029 Passed 473 for, 81 against, 9 abstainedPosition: For Majority line: For
12 Mar 2026Package travel and linked travel arrangements: make the protection of travellers more effective and simplify and clarify certain aspects Passed 537 for, 2 against, 24 abstainedPosition: For Majority line: For
12 Mar 2026Human trafficking and grave human rights violations linked to the recruitment of non-Russian nationals, in particular from Africa, for Russia’s war of aggression in Ukraine Adopted 479 for, 17 against, 43 abstainedPosition: For Majority line: For
12 Mar 2026The arbitrary detention of President Mohamed Bazoum by the junta in Niger Adopted 524 for, 2 against, 29 abstainedPosition: For Majority line: For
12 Mar 2026Case of Elene Khoshtaria and political prisoners under the Georgian Dream regime Adopted 438 for, 37 against, 81 abstainedPosition: For Majority line: For
12 Mar 2026Activities of the European Ombudsman – annual report 2024 Rejected 233 for, 250 against, 76 abstainedPosition: Against Majority line: Abstained
11 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Passed 458 for, 103 against, 63 abstainedPosition: For Majority line: For
11 Mar 2026Council of Europe Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law Consent given 455 for, 101 against, 74 abstainedPosition: Abstained Majority line: Abstained
11 Mar 2026EU-Ecuador Agreement: cooperation between Europol and the Ecuadorian authorities competent for combating serious crime and terrorism Consent given 586 for, 21 against, 11 abstainedPosition: For Majority line: For
11 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/004 BE/Tupperware – Belgium Passed 562 for, 53 against, 19 abstainedPosition: For Majority line: For
11 Mar 2026Framework Agreement on relations between the European Parliament and the European Commission Adopted 446 for, 100 against, 72 abstainedPosition: Abstained Majority line: Abstained
11 Mar 2026Gender pay and pension gap in the EU: state of play, challenges and the way forward, and developing guidelines for the better evaluation and fairer remuneration of work in female-dominated sectors Adopted 458 for, 72 against, 98 abstainedPosition: Abstained Majority line: Abstained
11 Mar 2026European Semester for economic policy coordination 2026 Adopted 392 for, 219 against, 18 abstainedPosition: Against Majority line: Against
11 Mar 2026European Semester for economic policy coordination: employment and social priorities for 2026 Adopted 404 for, 208 against, 20 abstainedPosition: Against Majority line: Against
11 Mar 2026EU enlargement strategy Adopted 385 for, 147 against, 98 abstainedPosition: For ≠ groupMajority line: Abstained

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 6 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within ECR

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Ivaylo VALCHEV ECRBulgaria88 % of 5 250 shared81 %
Stephen Nikola BARTULICA ECRCroatia87 % of 4 589 shared81 %
Diego SOLIER changed group ECRSpain87 % of 4 790 shared81 %
Reinis POZŅAKS ECRLatvia87 % of 5 148 shared81 %
Alessandro CIRIANI ECRItaly87 % of 4 653 shared81 %
Marco SQUARTA ECRItaly87 % of 4 311 shared81 %
Mario MANTOVANI ECRItaly87 % of 3 964 shared81 %
Roberts ZĪLE ECRLatvia87 % of 4 018 shared81 %
Giuseppe MILAZZO ECRItaly87 % of 2 585 shared81 %
Rihards KOLS ECRLatvia86 % of 4 994 shared81 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Branko GRIMS changed group No groupSlovenia73 % of 4 970 shared50 %
Nikola BARTŮŠEK changed group ECRCzechia71 % of 4 370 shared62 %
Tiago MOREIRA DE SÁ PatriotsPortugal71 % of 5 125 shared68 %
Juan Carlos GIRAUTA VIDAL PatriotsSpain70 % of 4 733 shared68 %
Antonín STANĚK PatriotsCzechia70 % of 2 973 shared68 %
Jorge BUXADÉ VILLALBA PatriotsSpain70 % of 5 089 shared68 %
Mireia BORRÁS PABÓN PatriotsSpain70 % of 4 989 shared68 %
Margarita DE LA PISA CARRIÓN PatriotsSpain70 % of 5 324 shared68 %
Sander SMIT changed group ECRNetherlands69 % of 3 555 shared50 %
Ondřej KOVAŘÍK Former memberPatriotsCzechia69 % of 1 172 shared68 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with JapanD-JP DelegationMember19 Sept 2024now
Delegation to the EU-Ukraine Parliamentary Association CommitteeD-UA DelegationSubstitute19 Sept 2024now
Delegation to the Euronest Parliamentary AssemblyDEPA Parliamentary assemblySubstitute19 Sept 2024now
Intergroup on Biodiversity, Hunting and CountrysideIG10-04 Intergroup / working groupMember4 Feb 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on DemographyIG10-09 Intergroup / working groupMember27 Jan 2025now
Intergroup on Freedom of Religion, Belief and ConscienceIG10-13 Intergroup / working groupMember27 Jan 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now

Show all 14 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Neurological health strategyShadow rapporteurSANT1 Sept 2026
No dossier namedOfficial delegationSANT7 Jul 2026
No dossier namedOfficial delegationENVI27 May 2026
No dossier namedOfficial delegationSANT30 Apr 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsShadow rapporteurSANT16 Apr 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsShadow rapporteurENVI25 Feb 2026
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT29 Jan 2026
Implementation and delivery of the Sustainable Development Goals in view of the 2026 High-Level Political ForumShadow rapporteurENVI15 Jan 2026
Acceleration of permit-granting for defence readiness projectsShadow rapporteur for an opinionENVI31 Oct 2025
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)RapporteurSANT28 Oct 2025

Show all 19 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

60 contributions recorded, 3 written statements; 12 on behalf of their group; 79 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) Speech · 1 minRead
16 Sept 2026The impact of the implementation of the Packaging and Packaging Waste Regulation (PPWR) on SMEs, its administrative burden and challenges for the European Single Market (debate) StatementRead
9 Jul 2026Joint communication on humanitarian aid (JOIN(2026)0025) (debate) Speech · 1 minRead
7 Jul 20262025 Commission report on Ukraine (debate) Speech · 1 minRead
17 Jun 2026Protecting EU citizens’ data from hybrid threats: the Lithuanian case (topical debate) on behalf of ECRSpeech · 2 minRead
19 May 2026EU governance under pressure – institutional responses to global challenges (debate) Speech · 1 minRead
19 May 2026EU cybersecurity and preparedness in view of advanced AI systems (debate) Speech · 1 minRead
18 May 2026European solidarity: key to securing medicine access in a shifting geopolitical era (debate) Speech · 1 minRead
29 Apr 2026Danger of normalising relations with Russia, including its participation in major cultural and sports events (debate) Speech · 1 minRead
28 Apr 2026Ensuring accountability and justice in response to Russia’s continued attacks against the civilian population in Ukraine (debate) Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 92

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
2 Sept 2026The new Packaging and Packaging Waste Regulation (PPWR) P-10-2026-003467Priority written questionNot yet answered
31 Jul 2026MOTION FOR A RESOLUTION on the need to combat migrant grooming gangs B-10-2026-0373Motion for a resolutionwith 80 co-authors—
14 Jul 2026Transparency and subsidiarity safeguards for LGBTIQ-related funding under AgoraEU and CERV+ E-10-2026-002903Written questionwith 11 co-authors25 Aug 2026
3 Jul 2026Follow-up to the European Citizens’ Panel on Preparedness E-10-2026-002778Written questionwith 9 co-authors21 Aug 2026
1 Jul 2026MOTION FOR A RESOLUTION on the Commission delegated regulation (EU) of 27 March 2026 amending Delegated Regulation (EU) 2020/688 as regards infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus and introducing a derogation for movements of registered equine animals B-10-2026-0342Motion for a resolutionwith 40 co-authors—
23 Jun 2026Evaluation and revision of the Biocidal Products Regulation to improve EU health preparedness and innovation E-10-2026-002574Written questionNot yet answered
18 Jun 2026Inclusion of surrogacy in the new EU strategy to combat trafficking in human beings E-10-2026-002535Written questionwith 19 co-authors4 Aug 2026
18 Jun 2026Use of European Social Fund Plus resources to finance abortion, and the definition of healthcare E-10-2026-002536Written questionwith 16 co-authors24 Sept 2026
16 Jun 2026MOTION FOR A RESOLUTION on the deteriorating situation of political prisoners in Belarus, in particular the case of Aliaksandra Pulinovich B-10-2026-0327Motion for a resolutionwith 19 co-authors—
15 Jun 2026MOTION FOR A RESOLUTION on Russia’s unacceptable provocative actions and drone incursions into Romania, the Baltic states and Finland B-10-2026-0308Motion for a resolutionwith 16 co-authors—

Show all 92 questions and motions

Amendments tabled in committee, 123

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT6
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT2
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6424
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6420
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT14
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT13
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT13
15 Jul 2026Amending Regulation (EU) 2023/1542 and Regulation (EU) 2024/1244 as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790846 ENVI8
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5312

Show all 123 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Aurelijus VERYGA”. Member record. memberId 256811. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256811?nb=all&page=4&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256811. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256811?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256811,
  author = {{EU Parl Watch Research}},
  title = {{Aurelijus VERYGA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256811?nb=all&page=4&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/256811?nb=all&page=4&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256811. Official source: https://www.europarl.europa.eu/meps/en/256811. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}